½ÃÀ庸°í¼­
»óǰÄÚµå
1607086

¼¼°èÀÇ ºÐȹ Ç÷·ù ¿¹ºñ·Â ½ÃÀå : Á¦Ç°º°, ¿ëµµº° ¿¹Ãø(2025-2030³â)

Fractional Flow Reserve Market by Product (FFR Guidewires, FFR Monitoring Systems), Application (Multi-Vessel Coronary Artery Disease, Single-Vessel Coronary Artery Disease) - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 198 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ºÐȹ Ç÷·ù ¿¹ºñ·Â ½ÃÀåÀº 2023³â¿¡ 11¾ï 2,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 12¾ï 4,000¸¸ ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 11.68%·Î ¼ºÀåÇϰí, 2030³â¿¡´Â 24¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ºÐȹ Ç÷·ù ¿¹ºñ·Â(FFR)Àº °ü»ó µ¿¸Æ ÇùÂøÀÇ Ç÷Çà ¿ªÇÐÀû Àǹ̸¦ °áÁ¤ÇϱâÀ§ÇÑ ÁöÇ¥ÀÌ¸ç °ü»ó µ¿¸Æ Á¶¿µ½Ã ħ½ÀÀûÀÎ ¹æ¹ýÀ¸·Î ÃøÁ¤µË´Ï´Ù. ½ºÅÙÆ® À¯Ä¡¼ú°ú °°Àº ÀÎÅͺ¥¿¡ °üÇÑ Áß¿äÇÑ °áÁ¤À» ³»¸®´Âµ¥ µµ¿òÀÌ µË´Ï´Ù. FFRÀÇ ¿ëµµ´Â º´¿ø, ½ÉÀå¼¾ÅÍ, ¿Ü·¡¼ö¼ú¼¾ÅÍ µî¿¡ ÆÛÁ® ÀÖ¾î ¾Ð·Â °¡À̵å¿ÍÀ̾î¿Í °è»ê¸ðµ¨ µîÀÇ ±â¼úÀÇ Áøº¸°¡ º¸±ÞÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. Àα¸ÀÇ °í·ÉÈ­, ½ÉÇ÷°üÁúȯÀÇ À¯º´·ü Áõ°¡, Àúħ½À ÀýÂ÷¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ¼ö¿ä µîÀ» µé ¼ö ÀÖÀ¸¸ç, ƯÈ÷ ÇコÄɾî ÀÎÇÁ¶ó°¡ Á¤ºñµÈ ½ÅÈï±¹¿¡¼­ Å« ±âȸ°¡ ź»ýÇϰí ÀÖ½À´Ï´Ù. ÇÏÁö¸¸ ÀÌ·¯ÇÑ ±âȸ¸¦ Ȱ¿ëÇÏ¿© ½ÃÀå¿¡¼­ ¹ßÀÚ±¹À» È®´ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ÇÕº´ÁõÀÇ ¸®½ºÅ©µµ ÀÌ·¯ÇÑ ÇѰ迡 ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ¿¬±¸°³¹ß ±âȸ°¡ ÀÍÀº Çõ½ÅÀûÀÎ ºÐ¾ß¿¡´Â ºñħ½ÀÀû FFR ±â¼úÀ̳ª ÀΰøÁö´ÉÀ» ÅëÇÕÇÑ °íµµÀÇ °è»ê ¸ðµ¨ µîÀÌ ÀÖ¾î À̵éÀº ÀýÂ÷ À§ÇèÀ» ´õ¿í ³·°Ô °¨¼ÒÇϰí Àû¿ë ¹üÀ§¸¦ ³ÐÈú ¼ö ÀÖ½À´Ï´Ù. ½ÃÀå °æÀïÀÌ Ä¡¿­ ÇØÁö°í ½ÃÀå ±âȸ¸¦ Ȱ¿ëÇϱâÀ§ÇÑ ±â¼ú Áøº¸¿Í Àü·«Àû ÇÕº´ÀÌ Áß¿äÇÕ´Ï´Ù. ±×¸®°í ÀýÂ÷ÀÇ ºñ¿ë È¿°ú °úÁ¦¸¦ È®º¸Çϱâ À§ÇÑ »õ·Î¿î ±â¼ú Çõ½Å¿¡ ÁßÁ¡À» µÎ¾î¾ß ÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 11¾ï 2,000¸¸ ´Þ·¯
ÃßÁ¤³â(2024) 12¾ï 4,000¸¸ ´Þ·¯
¿¹Ãø³â(2030) 24¾ï 3,000¸¸ ´Þ·¯
CAGR(%) 11.68%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â ºÐȹ Ç÷·ù ¿¹ºñ·Â ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

ºÐȹ Ç÷·ù ¿¹ºñ·Â ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. ÀÇ»ç °áÁ¤, »õ·Î¿î ºñÁî´Ï½º ±âȸÀÇ È¹µæÀ» ÇÒ ¼ö ÀÖ½À´Ï´Ù ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ» »Ó¸¸ ¾Æ´Ï¶ó ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ»º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ³ë³â Àα¸ Áõ°¡¿Í ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·üÀÇ »ó½Â
    • ÄÚ½ºÆ® ¸Þ¸®Æ®¿Í À¯¸®ÇÑ »óȯ ½Ã³ª¸®¿À
    • »õ·Ó°í Çõ½ÅÀûÀÎ ±â±âÀÇ ÀÎÆ®·Î´ö¼Ç Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ºÐȹ Ç÷·ù ¿¹ºñ·Â µµÀÔ¿¡ ´ëÇÑ ±âÁ¸ ½ÉÀå Àü¹®ÀÇÀÇ ÀúÇ×
  • ½ÃÀå ±âȸ
    • ±â±â °³¹ßÀ» À§ÇÑ ¿¬±¸°³¹ßºñ Áõ°¡
    • ½ÅÈï±¹ÀÇ ¼ºÀå °¡´É¼º
  • ½ÃÀåÀÇ °úÁ¦
    • ħ½ÀÀûÀÎ ºÐȹ Ç÷·ù ¿¹ºñ·ÂÀÇ ±â¼úÀû ÇѰè¿Í ´ëüǰÀÇ À̿밡´É¼º

Porter's Five Force : ºÐȹ Ç÷·ù ¿¹ºñ·Â ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Force Framework´Â ºÐȹ Ç÷·ù ¿¹ºñ·Â ½ÃÀå °æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇϴµ¥ µµ¿òÀÌ µË´Ï´Ù. ´õ °­ÀÎÇÑ ½ÃÀå¿¡¼­ Æ÷Áö¼Å´×À» º¸Àå ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ºÐȹ Ç÷·ù ¿¹ºñ·Â ½ÃÀå¿¡¼­ ¿ÜºÎ ¿µÇâÀ» ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ºÐȹ Ç÷·ù ¿¹ºñ·Â ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇϴµ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÏ¸é ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ°¡µÇ¾î ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ºÐȹ Ç÷·ù ¿¹ºñ·Â ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

ºÐȹ Ç÷·ù ¿¹ºñ·Â ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. À§ Æ÷Áö¼Å´×À» ¹àÇô À̸¦ ÅëÇØ ½ÃÀåÀÇ ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í, º¥´õ´Â °æÀïÀÌ °ÝÈ­ÇÏ´Â °¡¿îµ¥ ÀÚ½ÅÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» Çϱâ À§ÇØ ÇÊ¿äÇÕ´Ï´Ù. Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ºÐȹ Ç÷·ù ¿¹ºñ·Â ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ºÐȹ Ç÷·ù ¿¹ºñ·Â ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.

Àü·«ºÐ¼®°ú Ãßõ : ºÐȹ Ç÷·ù ¿¹ºñ·Â ½ÃÀå¿¡¼­ ¼º°øÀ» À§ÇÑ ±æÀ» ±×¸³´Ï´Ù.

ºÐȹ Ç÷·ù ¿¹ºñ·Â ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ Á¢±Ù¹ýÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» ÀÌ·ç±âÀ§ÇÑ ½Ã½ºÅÛÀ» ±¸Ãà ÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ: ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­: ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ¡¤Ã¶¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • °í·ÉÀÚ Àα¸ Áõ°¡¿Í ½ÉÇ÷°ü ÁúȯÀÇ ÀÌȯÀ²ÀÇ »ó½Â
      • ÄÚ½ºÆ® ¸Þ¸®Æ®¿Í À¯¸®ÇÑ »óȯ ½Ã³ª¸®¿À
      • »õ·Î¿î Çõ½ÅÀûÀÎ µð¹ÙÀ̽ºÀÇ µµÀÔ Áõ°¡
    • ¾ïÁ¦¿äÀÎ
      • ±âÁ¸ ½ÉÀå Àü¹®Àǰ¡ ºÐȹ Ç÷·ù ¿¹ºñ·ÂÀ» ä¿ëÇÏ´Â °Í¿¡ ÀúÇ×ÇÑ´Ù
    • ±âȸ
      • ±â±â °³¹ßÀ» À§ÇÑ ¿¬±¸°³¹ßºñ Áõ°¡
      • ½ÅÈï±¹ÀÇ ¼ºÀå °¡´É¼º
    • °úÁ¦
      • ħ½ÀÀûÀÎ ºÐȹ Ç÷·ù ¿¹ºñ·ÂÀÇ ±â¼úÀû ÇѰè¿Í ´ëüǰÀÇ À̿밡´É¼º
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ºÐȹ Ç÷·ù ¿¹ºñ·Â ½ÃÀå : Á¦Ç°º°

  • FFR °¡À̵å¿ÍÀ̾î
  • FFR ¸ð´ÏÅ͸µ ½Ã½ºÅÛ

Á¦7Àå ºÐȹ Ç÷·ù ¿¹ºñ·Â ½ÃÀå : ¿ëµµº°

  • ´ÙÁö°üµ¿¸ÆÁúȯ
  • ´ÜÁö°üµ¿¸ÆÁúȯ

Á¦8Àå ¾Æ¸Þ¸®Ä«ÀÇ ºÐȹ Ç÷·ù ¿¹ºñ·Â ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦9Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ºÐȹ Ç÷·ù ¿¹ºñ·Â ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦10Àå À¯·´¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ºÐȹ Ç÷·ù ¿¹ºñ·Â ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦11Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • Abbott Laboratories
  • ACIST Medical Systems, Inc.
  • Apollo Hospitals Enterprise Ltd.
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Bracco SpA
  • CathWork Inc.
  • GE HealthCare by General Electric
  • HeartFlow, Inc.
  • Koninklijke Philips NV
  • Medis Medical Imaging Systems BV
  • Medtronic plc
  • Opsens, Inc.
  • Pie Medical Imaging
  • Siemens Healthineers AG
JHS 24.12.17

The Fractional Flow Reserve Market was valued at USD 1.12 billion in 2023, expected to reach USD 1.24 billion in 2024, and is projected to grow at a CAGR of 11.68%, to USD 2.43 billion by 2030.

Fractional Flow Reserve (FFR) is an index used to determine the hemodynamic significance of coronary arterial stenoses, measured using invasive methods during coronary angiography. This assessment helps cardiologists make critical decisions regarding interventions like angioplasty or stenting. FFR has grown essential, particularly given the rising prevalence of coronary artery disease, as it offers a more precise measure than traditional angiograms, reducing unnecessary procedures. The application of FFR spans across hospitals, cardiac centers, and ambulatory surgical centers, with increasing adoption encouraged by advancements in technologies such as pressure guidewires and computational models. Key growth factors for the FFR market include the aging global population, increased prevalence of cardiovascular diseases, and the continuous demand for minimally invasive procedures, giving rise to significant opportunities, particularly in emerging economies with improving healthcare infrastructures. Companies focusing on product enhancements and strategic collaborations can leverage these opportunities to expand their market footprint. However, challenges like high costs associated with FFR measurement, technical complexities of the procedure, and a shortage of skilled personnel could hinder market growth. The risks of procedural complications also add to these limitations. Innovative areas ripe for research and development include non-invasive FFR techniques and advanced computation models integrating artificial intelligence, which could further reduce the procedural risks and broaden the application scope. The nature of the market is highly competitive, with a strong emphasis on technological advancements and strategic mergers to capitalize on market opportunities. Firms should focus on investing in training programs to counter skill shortages and further innovations to ensure cost-effectiveness of procedures. By diligently addressing these challenges and strategically leveraging growth opportunities, businesses could significantly enhance their position in the FFR market.

KEY MARKET STATISTICS
Base Year [2023] USD 1.12 billion
Estimated Year [2024] USD 1.24 billion
Forecast Year [2030] USD 2.43 billion
CAGR (%) 11.68%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Fractional Flow Reserve Market

The Fractional Flow Reserve Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising geriatric population and rising prevalence of cardiovascular diseases
    • Cost benefits and favorable reimbursement scenario
    • Increasing introduction of new and innovative devices
  • Market Restraints
    • The resistance of traditional cardiologist to adopt fractional flow reverse
  • Market Opportunities
    • Rising expenditure in research & development for development of equipment
    • Growth potential in emerging economies
  • Market Challenges
    • Technical limitations of invasive fractional flow reserve & availability of substitute

Porter's Five Forces: A Strategic Tool for Navigating the Fractional Flow Reserve Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Fractional Flow Reserve Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Fractional Flow Reserve Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Fractional Flow Reserve Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Fractional Flow Reserve Market

A detailed market share analysis in the Fractional Flow Reserve Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Fractional Flow Reserve Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Fractional Flow Reserve Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Fractional Flow Reserve Market

A strategic analysis of the Fractional Flow Reserve Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Fractional Flow Reserve Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACIST Medical Systems, Inc., Apollo Hospitals Enterprise Ltd., B. Braun Melsungen AG, Boston Scientific Corporation, Bracco S.p.A., CathWork Inc., GE HealthCare by General Electric, HeartFlow, Inc., Koninklijke Philips N.V., Medis Medical Imaging Systems BV, Medtronic plc, Opsens, Inc., Pie Medical Imaging, and Siemens Healthineers AG.

Market Segmentation & Coverage

This research report categorizes the Fractional Flow Reserve Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across FFR Guidewires and FFR Monitoring Systems.
  • Based on Application, market is studied across Multi-Vessel Coronary Artery Disease and Single-Vessel Coronary Artery Disease.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising geriatric population and rising prevalence of cardiovascular diseases
      • 5.1.1.2. Cost benefits and favorable reimbursement scenario
      • 5.1.1.3. Increasing introduction of new and innovative devices
    • 5.1.2. Restraints
      • 5.1.2.1. The resistance of traditional cardiologist to adopt fractional flow reverse
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising expenditure in research & development for development of equipment
      • 5.1.3.2. Growth potential in emerging economies
    • 5.1.4. Challenges
      • 5.1.4.1. Technical limitations of invasive fractional flow reserve & availability of substitute
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Fractional Flow Reserve Market, by Product

  • 6.1. Introduction
  • 6.2. FFR Guidewires
  • 6.3. FFR Monitoring Systems

7. Fractional Flow Reserve Market, by Application

  • 7.1. Introduction
  • 7.2. Multi-Vessel Coronary Artery Disease
  • 7.3. Single-Vessel Coronary Artery Disease

8. Americas Fractional Flow Reserve Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Fractional Flow Reserve Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Fractional Flow Reserve Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. ACIST Medical Systems, Inc.
  • 3. Apollo Hospitals Enterprise Ltd.
  • 4. B. Braun Melsungen AG
  • 5. Boston Scientific Corporation
  • 6. Bracco S.p.A.
  • 7. CathWork Inc.
  • 8. GE HealthCare by General Electric
  • 9. HeartFlow, Inc.
  • 10. Koninklijke Philips N.V.
  • 11. Medis Medical Imaging Systems BV
  • 12. Medtronic plc
  • 13. Opsens, Inc.
  • 14. Pie Medical Imaging
  • 15. Siemens Healthineers AG
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦